CUMBERLAND PHARMACEUTICALS INC Cash And Cash Equivalents At Carrying Value

Quick Answer

CUMBERLAND PHARMACEUTICALS INC reported Cash And Cash Equivalents At Carrying Value of $11.44 million for the year ending 2025.

  • CUMBERLAND PHARMACEUTICALS INC showed a decrease of -36.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from CUMBERLAND PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 9, 2026.
  • XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 18 years of available data (2008 to 2025), CUMBERLAND PHARMACEUTICALS INC's Cash And Cash Equivalents At Carrying Value has declined by 3.3%.
  • Historical annual values: Fiscal year 2025: $11.44 million | Fiscal year 2024: $17.96 million | Fiscal year 2023: $18.32 million | Fiscal year 2022: $19.76 million | Fiscal year 2021: $27.04 million | Fiscal year 2020: $24.75 million | Fiscal year 2019: $28.21 million | Fiscal year 2018: $27.94 million | Fiscal year 2017: $45.41 million | Fiscal year 2016: $34.51 million | Fiscal year 2015: $38.20 million | Fiscal year 2014: $39.87 million | Fiscal year 2013: $40.87 million | Fiscal year 2012: $54.35 million | Fiscal year 2011: $70.60 million | Fiscal year 2010: $65.89 million | Fiscal year 2009: $78.70 million | Fiscal year 2008: $11.83 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: